Drug intelligence / Profile preview

rhynchophylline

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intranasal, Intraperitoneal
01

Overview

**Rhynchophylline** is a natural tetracyclic oxindole alkaloid derived primarily from *Uncaria rhynchophylla*, a traditional medicinal plant. It is recognized for its neuroprotective, anti-inflammatory, antihypertensive, antiarrhythmic, anti-addictive, anticonvulsant, and sedative effects. Mechanistically, rhynchophylline acts as a modulator of neurotransmitters, suppressor of calcium and potassium channels, and has demonstrated inhibition of ephrin type A receptor 4 (EphA4) tyrosine kinase and suppression of inflammation via inhibition of MAPK/NF-κB signaling. It has been shown to reduce neuronal apoptosis and inflammation, prevent neurotoxicity in PD and AD models, and modulate several metabolic and signaling pathways relevant to neurodegenerative and cardiovascular diseases[1][3].

Other names
rhynchophyllinrhyncophyllineRHYNCHOPHYLLINERHYNCHOLPHYLLINEHook vine extract
02

Targets

EPHA4KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)RYR2 (Ryanodine receptor 2)CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on rhynchophylline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhynchophylline.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call